The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension

J Glaucoma. 2010 Aug;19(6):424-6. doi: 10.1097/IJG.0b013e3181bdb586.
No abstract available

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amides / administration & dosage
  • Amides / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Bimatoprost
  • Cloprostenol / administration & dosage
  • Cloprostenol / analogs & derivatives*
  • Cloprostenol / therapeutic use
  • Double-Blind Method
  • Drug Combinations
  • Drug Therapy, Combination
  • Female
  • Glaucoma / drug therapy*
  • Humans
  • Intraocular Pressure / drug effects*
  • Male
  • Middle Aged
  • Ocular Hypertension / drug therapy
  • Timolol / adverse effects
  • Timolol / therapeutic use*
  • Tonometry, Ocular
  • Treatment Outcome

Substances

  • Amides
  • Antihypertensive Agents
  • Drug Combinations
  • Cloprostenol
  • Timolol
  • Bimatoprost

Associated data

  • ClinicalTrials.gov/NCT00332072
  • ClinicalTrials.gov/NCT00332540